ClinicalTrials.gg
Drug

Mitapivat clinical trials

Also written AG-348.

studies test it
28
open now
5
in phase 3
11
first study started
2014

How each study uses mitapivat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the mitapivat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
17 Feb 2022 · PYRUKYND · NDA 216196 (FDA, Drugs@FDA)
European Union
9 Nov 2022 · Pyrukynd · EMEA/H/C/005540 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mitapivat
18
Mitapivat sulfate
16

Brand

PYRUKYND®
1

Development codes

AG-348
26

Studies by the year they started

28 studies that test it; most in 2026 (4)

Studies that test mitapivat, by start year
YearStudies
20142
20151
20171
20183
20193
20203
20213
20223
20233
20241
20251
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
10
Phase 2
7
Phase 3
11
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 4

Agios Pharmaceuticals, Inc. (24) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University Health Network, Toronto (1) · National Institutes of Health Clinical Center (CC) (1) · EuroBloodNet Association (1)

Often tested with

Tested in the same studies.

Midazolam (1)

Studies

Open first, then newest update. How each study uses mitapivat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 28

See all 28 studies that test mitapivat →

Given beside what is tested · 1 — mitapivat is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with mitapivat

Codes

What other systems call mitapivat · ClinicalTrials.gg INT001174

  • MeSH (NLM) C000634504mitapivatConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2WTV10SIKHMITAPIVATConfirmed FDA, NLM, Wikidata
  • RxNorm 2594468One source FDA
  • Wikidata Q105337735mitapivatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C157039MitapivatOne source FDA
  • DrugBank DB16236One source Wikidata

Also registered as mitapivat sulfate (UNII N4JTA67V3O · RxNorm 2595574).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.